Vistagen Therapeutics, Inc. VTGN
0.19 USD 0.00 (-0.48%)
Nov 12, 2026, 12:26 PM EST
0.18 Day range 0.1901
0.16 52-week range 5.14
- YTD
- -71.68%
- 1 year
- -95.41%
VTGN revenue history
Revenue is income from the company’s ordinary business activities.
1,269,000 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | 1,269,000 | 783,000 | 161.11% |
| FY 2025 | 2025-03-31 | 486,000 | -578,000 | -54.32% |
| FY 2024 | 2024-03-31 | 1,064,000 | 1,291,000 | Not meaningful |
| FY 2023 | 2023-03-31 | -227,000 | -1,335,900 | -120.47% |
| FY 2022 | 2022-03-31 | 1,108,900 | 19,400 | 1.78% |
| FY 2021 | 2021-03-31 | 1,089,500 | 1,089,500 | Not meaningful |
| FY 2020 | 2020-03-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-03-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-03-31 | 0 | -1,250,000 | -100.00% |
| FY 2017 | 2017-03-31 | 1,250,000 | 1,250,000 | Not meaningful |
| FY 2016 | 2016-03-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-03-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-03-31 | 0 | -200,400 | -100.00% |
| FY 2013 | 2013-03-31 | 200,400 | -1,141,800 | -85.07% |
| FY 2012 | 2012-03-31 | 1,342,200 | -728,800 | -35.19% |
| FY 2011 | 2011-03-31 | 2,071,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-06-27T05:09:21.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.